Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
Anaptys (Nasdaq: ANAB) announced that chief financial officer Chris Murphy will present at the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Anaptys (Nasdaq: ANAB) announced that chief financial officer Chris Murphy will present at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, Sept. 15, 2026, at 3:30 p.m. ET. A live webcast and at least 30-day replay will be accessible via the investor section of Anaptys’ website.
Details
News Market Reaction – ANAB
On Sep 2, the first trading day after this news, ANAB closed 1.09% above the previous close. Our momentum scanner recorded 2 alerts for this stock that day. Relative volume reached 1.7x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 2 session.
Key Figures
- Conference edition
- 28th annual
- H.C. Wainwright Global Investment Conference
- Presentation date
- Sept. 15, 2026
- Scheduled conference presentation
- Presentation time
- 3:30pm ET
- Scheduled presentation start
- Replay availability
- at least 30 days
- Webcast replay following the event
Historical Context
-
Reported collaboration revenue, cash, net loss, royalties, repurchase plan, and PDUFA date.
-
Appointed Christopher M. Murphy CFO and Owen Hughes director, effective May 11.
-
Announced CEO participation in a fireside chat at H.C. Wainwright royalty conference.
-
Reported pivotal phase III imsidolimab study publication and FDA BLA target date.
-
Dismissed Tesaro's anticipatory breach claim in Delaware Chancery Court.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that Chris Murphy, chief financial officer, is scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, Sept. 15, 2026. The presentation is scheduled to begin at 3:30pm ET.
A live webcast of the presentation will be available on the investor section of the Anaptys website at https://ir.anaptysbio.com/presentations-and-events. A replay of the webcast will be available for at least 30 days following the event.
About Anaptys
Anaptys manages the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, with a focus on protecting and returning the value of its royalties to shareholders. To learn more, visit www.AnaptysBio.com or follow us on LinkedIn.
Contact:
Chris Murphy
Chief Financial Officer
investors@anaptysbio.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.